Moreover, Wang et al demonstrated that IGF-I improves diabetic cardiomyopathy as a serious complication of diabetes mellitus via antioxidative and anti-inflammatory mechanisms, as well as with regulation of the Akt/GSK-3 signaling pathway.39 Here, IGF1 is linked to diabetic cardiomyopathy.